Slides: Expert Insight Key Data From ASCO 2023 Informing Treatment for Endometrial, Cervical, and Ovarian Cancers
Download these slides from Kathleen Moore, MD, and Nicoleta Colombo, MD, PhD, with key data for gynecologic cancers presented at the 2023 ASCO Annual Meeting, including practice updated results for immunotherapy in cervical cancer, data for novel immunotherapy-based combination in ovarian, and key results from combination immunotherapy plus chemotherapy combination as frontline treatment for advanced endometrial cancer.
Associate Professor of Obstetrics and Gynecology University of Milan-Bicocca European Institute of Oncology Milan, Italy
Kathleen Moore, MD, MS
Associate Director, Clinical Research Virginia kerley Cade Chair in Developmental Therapeutics Director, TSET Phase 1 Clinical Trials Unit Professor Department of Gynecologic Oncology Stephenson Cancer Center at the University of Oklahoma Oklahoma City, Oklahoma
Provided by Clinical Care Options LLC
This educational activity is supported by educational grants from AstraZeneca, GlaxoSmithKline, Merck Sharp & Dohme Corp, Novocure, Genmab and Seagen.
Merck Sharp & Dohme Corp.
Select date of attendance
Welcome to the CCO site
Thank you for your interest in CCO content. As a guest, please complete the following information. This data helps ensure our continued delivery of impactful medical education.
You will be sent to the previous page if you close this window.